Orum Therapeutics Unveils AACR 2026 Preclinical Data on ORM-1153 Showing Broad AML Activity and Improved Safety Potential Orum Therapeutics has unveiled new preclinical findings for its investigational therapy ORM-1153, highlighting its potential as a next-generation treatment for acute myeloid leukemia…
SingleCell Biotechnology Unveils High-Throughput Single-Cell Assay Linking Clonal Growth to Molecular Profiles at AACR Single-cell analysis is rapidly reshaping how researchers understand cancer, particularly in the context of tumor heterogeneity and treatment resistance. At the American Association for Cancer Research…
AOP Health US Secures FDA Approval for RAPIBLYK® (Landiolol) in Pediatric SVT Patients AOP Health US, LLC has announced a major regulatory milestone with the U.S. Food and Drug Administration (FDA) approving RAPIBLYK® (landiolol) for the treatment of pediatric patients…
City of Champions Golf Tournament Approaches $1 Million for Prostate Cancer Research The fourth annual City of Champions Golf Tournament, led by Paul M. Wilson, CEO of NetReputation.com, and co-host Michael Muldowney, is approaching a significant milestone in its mission…
SurGenTec Wins FDA 510(k) Clearance for TiLink™ SI Joint Fusion System with Navigation Compatibility SurGenTec, LLC, a company recognized for its innovation in spine and orthopedic technologies, has announced that it has received 510(k) clearance from the U.S. Food and…
Star Gala Raises Record $3.7 Million to Advance Children’s Minnesota Mental Health Care The 34th annual Star Gala hosted by Children’s Minnesota marked a milestone year, raising an unprecedented $3.7 million in support of the organization’s mental health program. Held…
Eradivir to Showcase Novel Antiviral Approaches at ESCMID Global and ICAR 2026 Eradivir a clinical-stage biotechnology company focused on developing innovative therapies for infectious diseases, has announced its participation in two major international scientific conferences in 2026. The company will…
A Milestone for Keratoconus Treatment Glaukos Corporation has announced a significant regulatory and reimbursement milestone for its innovative therapy, Epioxa™ (Epioxa HD / Epioxa), designed to treat Keratoconus—a progressive and potentially sight-threatening corneal condition. The Centers for Medicare and Medicaid…
CareDx to Divest Lab Products Business for $170 Million, Reports Strong Q1 2026 Growth CareDx, Inc. has announced a definitive agreement to sell its Lab Products business to Eurobio Scientific for $170 million in cash. The decision marks a significant…
Bayer Canada Backs a Transformative Step in Medical Education Bayer Canada has announced a significant initiative to support the launch of the new School of Medicine at Simon Fraser University (SFU). This collaboration marks a major milestone in advancing healthcare…
GNQ Insilico and IBM Collaborate to Advance Precision Medicine and Clinical AI Adoption In a significant move aimed at transforming the future of healthcare and drug development, GNQ Insilico has announced a strategic collaboration with IBM. This partnership is designed…
Covalon Technologies Demonstrates Strong Momentum Across Key Healthcare Segments Covalon Technologies Ltd., a leader in advanced medical technologies, has announced a series of notable milestones that underscore its accelerating commercial momentum and expanding presence across critical healthcare segments. The company…